Endometriosis pathophysiology and biomarkers: a review of immunological, genetic, hormonal, and metabolic mechanisms

In: Reproductive and Developmental Medicine · 2026 · doi:10.1097/rd9.0000000000000163 · W7151230315
article OA: diamond CC0

Abstract

Endometriosis is a multifactorial disease characterized by the presence of endometrial-like tissue outside the uterus, leading to chronic pain and infertility. Its pathophysiology involves complex interactions between immune dysfunction, genetic and epigenetic alterations, hormonal imbalance, oxidative stress, and microbiota dysbiosis, which drive inflammation and ectopic tissue growth. Understanding these mechanisms is essential for identifying potential biomarkers and developing effective therapeutic strategies. This narrative review synthesizes evidence from 105 English-language studies published between 2012 and 2025 and identified through searches in PubMed, Scopus, MEDLINE, and Google Scholar using Medical Subject Headings terms and Boolean operators. Findings were grouped into five domains: immune dysfunction, genetic and epigenetic factors, oxidative stress, hormone dysregulation, and microbiota. Immune alterations contribute to chronic inflammation, lesion persistence, and oxidative stress. Genetic and epigenetic changes, including DNA methylation and microRNA dysregulation, affect hormonal regulation. Circulating cell-free DNA has emerged as a promising diagnostic biomarker, and the microbiota modulates immune responses and oxidative stress, influencing disease progression. Integrating these domains provides a comprehensive framework for understanding endometriosis and highlights opportunities for biomarker development and novel therapies. Advances in diagnostic tools and targeted interventions may improve early detection, reduce recurrence, support fertility preservation, and facilitate personalized management of the disease.
Full text 2,734 characters · extracted from oa-html · click to expand
Endometriosis is a multifactorial disease characterized by the presence of endometrial-like tissue outside the uterus, leading to chronic pain and infertility. Its pathophysiology involves complex interactions between immune dysfunction, genetic and epigenetic alterations, hormonal imbalance, oxidative stress, and microbiota dysbiosis, which drive inflammation and ectopic tissue growth. Understanding these mechanisms is essential for identifying potential biomarkers and developing effective therapeutic strategies. This narrative review synthesizes evidence from 105 English-language studies published between 2012 and 2025 and identified through searches in PubMed, Scopus, MEDLINE, and Google Scholar using Medical Subject Headings terms and Boolean operators. Findings were grouped into five domains: immune dysfunction, genetic and epigenetic factors, oxidative stress, hormone dysregulation, and microbiota. Immune alterations contribute to chronic inflammation, lesion persistence, and oxidative stress. Genetic and epigenetic changes, including DNA methylation and microRNA dysregulation, affect hormonal regulation. Circulating cell-free DNA has emerged as a promising diagnostic biomarker, and the microbiota modulates immune responses and oxidative stress, influencing disease progression. Integrating these domains provides a comprehensive framework for understanding endometriosis and highlights opportunities for biomarker development and novel therapies. Advances in diagnostic tools and targeted interventions may improve early detection, reduce recurrence, support fertility preservation, and facilitate personalized management of the disease. Endometriosis pathophysiology and biomarkers: a review of immunological, genetic, hormonal, and metabolic mechanisms - Open - PAP Plain Language SummaryEndometriosis is a multifactorial disease in which endometrial-like tissue grows outside the uterus, causing chronic pain and infertility. This narrative review analyzed 105 English-language studies (2012–2025) from PubMed, Scopus, MEDLINE, and Google Scholar to clarify its mechanisms. Evidence was organized into five domains: immune dysfunction, genetic and epigenetic factors, oxidative stress, hormone dysregulation, and microbiota. Immune and oxidative changes sustain chronic inflammation and lesion persistence, while DNA methylation and microRNA dysregulation disturb hormonal regulation. Circulating cell-free DNA is emerging as a promising biomarker, and microbiota influences immune responses and oxidative stress. Integrating these domains may support earlier diagnosis, targeted therapies, reduced recurrence, and more personalized management. Text is machine generated and may contain inaccuracies. FAQ

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-07-07T06:01:32.521272+00:00
License: CC0 · commercial use OK